National Australia Bank Ltd, Medibank Private Ltd and Rio Tinto Limited: Should you buy?

Analysts are forecasting bigger dividends for shareholders of National Australia Bank Ltd (ASX:NAB), Medibank Private Ltd (ASX:MPL) and Rio Tinto Limited (ASX:RIO) in 2015. But are they a buy?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

With interest rates tipped to remain low throughout 2015, blue-chip dividend stocks are likely to remain the focus for many Australian investors.

Indeed with term deposits and fixed income investments offering taxable returns of 3% or 4%, the tax effective fully franked dividend yields in excess of 5% on offer in the share market look very appealing.

The very best dividends are those which are not only sustainable, but growing.

And three companies which are being tipped by analysts to grow their payout in coming years are National Australia Bank Ltd (ASX: NAB), Medibank Private Ltd (ASX: MPL) and Rio Tinto Limited (ASX: RIO).

However investors considering buying shares in any of these companies must first understand the risks because a consistent share price fall could easily whip out the perceived benefit of a forecast dividend payment.

Here's what you need to know…

NAB – our largest bank by assets – is currently forecast to pay a 6.5% fully franked dividend in 2015. After announcing around $1.5 billion of write-offs earlier in the year, NAB's new CEO Andrew Thorburn has made it his goal to finally rid the bank of its troubled foreign assets to focus solely on Australia and New Zealand. However it should be noted many management teams have come and gone trying to do the same, while its share price has significantly lagged its peers. So whilst the shares may look cheap (it trades on a forward P/E ratio of just 11), the comparatively low price may be justified.

Medibank Private was the hottest IPO in 2014 and no doubt retail investors who purchased shares at $2.00 in November would be happy with its 14.5% gains thus far. However at today's price of $2.29, Medibank shares change hands at almost 24 times next year's earnings. That means, much of its growth is already baked into the market price and will likely make it susceptible to sell offs at the slightest sign of weakness. As a result of a lofty valuation, its 2.1% fully franked dividend yield for 2015 doesn't appear worthy of an investment today.

Lastly Rio Tinto has committed to increased shareholders returns in the coming year and analysts are forecasting a 4.5% fully franked dividend yield. However Rio is staring down the barrel of low iron ore prices (the commodity has fallen over 50% in 2014) as well as lacklustre coal and uranium prices. Given iron ore accounted for over 90% of FY14's profits, investors would be wise to keep their distance in 2015.

Motley Fool Contributor Owen Raszkiewicz owns shares of Medibank Private. You can follow Owen on Twitter @ASXinvest.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »